Literature DB >> 17576514

Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro.

K V Gopal1, B R Miller, G W Gross.   

Abstract

Methylphenidate (MPH) is the drug of choice in the treatment of attention deficit and hyperactivity disorders. Although a popular drug, concentration-dependent electrophysiological alteration or impairment (functional toxicity) and reversibility, have not been quantified. This study used spontaneously active neuronal networks growing on microelectrode arrays (MEA) to investigate functional neurotoxicity of MPH by assessing its acute and sub-chronic electrophysiologic effects on auditory cortex networks (ACN) and frontal cortex networks (FCN) at concentrations that reflect clinical doses and overdoses. Acute exposure to 1-300 microM MPH induced concentration-dependent inhibition of spontaneous activity with spike rate IC(50) values (concentration inducing 50% inhibition) of 112.9 +/- 18.6 and 108.0 +/- 18.9 microM for ACNs and FCNs respectively. Sub-chronic exposure to 1 mM MPH for 24 h blocked all activity followed by partial spontaneous recovery after 15 h. Tyrosine hydroxylase immunocytochemistry analysis indicated positive staining of neurons, confirming the presence of catecholaminergic neurons in cultured cortex networks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576514     DOI: 10.1007/s00702-007-0759-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  37 in total

Review 1.  Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene Jack Wang; Yu Shin Ding; Samuel J Gatley
Journal:  Eur Neuropsychopharmacol       Date:  2002-12       Impact factor: 4.600

2.  The Staggered Spondaic Word Test. A ten-minute look at the central nervous system through the ears.

Authors:  J Katz; P S Smith
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Theresa Harpold; Stephanie Dunkel; Meghan Dougherty; Megan Aleardi; Thomas Spencer
Journal:  Biol Psychiatry       Date:  2005-12-20       Impact factor: 13.382

4.  NMDA receptor-dependent periodic oscillations in cultured spinal cord networks.

Authors:  E W Keefer; A Gramowski; G W Gross
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

Review 5.  Catecholamines in attention-deficit hyperactivity disorder: current perspectives.

Authors:  S R Pliszka; J T McCracken; J W Maas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-03       Impact factor: 8.829

6.  Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Patricia E Molina; Jean Logan; S John Gatley; Andrew Gifford; Yu-Shin Ding; Christopher Wong; Naomi R Pappas; Wei Zhu; James M Swanson
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

7.  Dopamine transporter density in patients with attention deficit hyperactivity disorder.

Authors:  D D Dougherty; A A Bonab; T J Spencer; S L Rauch; B K Madras; A J Fischman
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

8.  Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus.

Authors:  Masaru Ishimatsu; Yuri Kidani; Akira Tsuda; Takashi Akasu
Journal:  J Neurophysiol       Date:  2002-03       Impact factor: 2.714

9.  Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity.

Authors:  Jacquelyn K Huff; Malonne I Davies
Journal:  J Pharm Biomed Anal       Date:  2002-07-31       Impact factor: 3.935

10.  Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder.

Authors:  C C E Overtoom; M N Verbaten; C Kemner; J L Kenemans; H van Engeland; J K Buitelaar; M W van der Molen; J van der Gugten; H Westenberg; R A A Maes; H S Koelega
Journal:  Behav Brain Res       Date:  2003-10-17       Impact factor: 3.332

View more
  6 in total

1.  Establishment of a Long-Term Chick Forebrain Neuronal Culture on a Microelectrode Array Platform.

Authors:  Serena Y Kuang; Ting Huang; Zhonghai Wang; Yongliang Lin; Mark Kindy; Tingfei Xi; Bruce Z Gao
Journal:  RSC Adv       Date:  2015-06-18       Impact factor: 3.361

2.  The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial.

Authors:  Ludger Tebartz van Elst; Simon Maier; Stefan Klöppel; Erika Graf; Carola Killius; Marthe Rump; Esther Sobanski; Dieter Ebert; Mathias Berger; Andreas Warnke; Swantje Matthies; Evgeniy Perlov; Alexandra Philipsen
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

3.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

4.  Methylphenidate-triggered ROS generation promotes caveolae-mediated transcytosis via Rac1 signaling and c-Src-dependent caveolin-1 phosphorylation in human brain endothelial cells.

Authors:  Vanessa Coelho-Santos; Renato Socodato; Camila Portugal; Ricardo A Leitão; Manuel Rito; Marcos Barbosa; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Richard D Minshall; Carlos Fontes-Ribeiro; Teresa Summavielle; João B Relvas; Ana P Silva
Journal:  Cell Mol Life Sci       Date:  2016-07-04       Impact factor: 9.261

5.  Antioxidants L-carnitine and D-methionine modulate neuronal activity through GABAergic inhibition.

Authors:  Calvin Wu; Kamakshi V Gopal; Ernest J Moore; Guenter W Gross
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

6.  Assessment of styrene oxide neurotoxicity using in vitro auditory cortex networks.

Authors:  Kamakshi V Gopal; Calvin Wu; Ernest J Moore; Guenter W Gross
Journal:  ISRN Otolaryngol       Date:  2011-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.